Skip to content

Cumberland Pharmaceuticals CPIX Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

PTH
Pelthos Therapeutics Inc.PTHS
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Organon logo
OrganonOGN
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's common stock, shares, outstanding?
Cumberland Pharmaceuticals (CPIX) reported common stock, shares, outstanding of $14.98M in Q1 2026.
How has Cumberland Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
Cumberland Pharmaceuticals's common stock, shares, outstanding increased by 0.1% year-over-year, from $14.96M to $14.98M.
What is the long-term trend for Cumberland Pharmaceuticals's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's common stock, shares, outstanding has grown at a -0.0% compound annual growth rate (CAGR), from $14.99M to $14.96M.